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Sepsis is a complex disease that is characterized by activation and inhibition of different cell
signaling pathways according to the disease stage. Here, we evaluated genes involved in
the TLR signaling pathway, oxidative phosphorylation and oxidative metabolism, aiming to
assess their interactions and resulting cell functions and pathways that are disturbed in sep-
tic patients.
Materials and methods
Blood samples were obtained from 16 patients with sepsis secondary to community
acquired pneumonia at admission (D0), and after 7 days (D7, N = 10) of therapy. Samples
were also collected from 8 healthy volunteers who were matched according to age and gen-
der. Gene expression of 84 genes was performed by real-time polymerase chain reactions.
Their expression was considered up- or down-regulated when the fold change was greater
than 1.5 compared to the healthy volunteers. A p-value of 0.05 was considered
significant.
Results
Twenty-two genes were differently expressed in D0 samples; most of them were down-reg-
ulated. When gene expression was analyzed according to the outcomes, higher number of
altered genes and a higher intensity in the disturbance was observed in non-survivor than in
survivor patients. The canonical pathways altered in D0 samples included interferon and
iNOS signaling; the role of JAK1, JAK2 and TYK2 in interferon signaling; mitochondrial dys-
function; and superoxide radical degradation pathways. When analyzed according to out-
comes, different pathways were disturbed in surviving and non-surviving patients.
Mitochondrial dysfunction, oxidative phosphorylation and superoxide radical degradation
pathway were among the most altered in non-surviving patients.
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Conclusion
Our data show changes in the expression of genes belonging to the interacting TLR cas-
cades, NADPH-oxidase and oxidative phosphorylation. Importantly, distinct patterns are
clearly observed in surviving and non-surviving patients. Interferon signaling, marked by
changes in JAK-STAT modulation, had prominent changes in both survivors and non-survi-
vors, whereas the redox imbalance (iNOS signaling, oxidative phosphorylation and superox-
ide radical degradation) affecting mitochondrial functions was prominent in non-surviving
patients.
Introduction
Sepsis is a complex disease that is characterized by activation and inhibition of different cell
signaling pathways according to the disease stage [1]. Recently, a new consensus defined sepsis
as a life-threatening organ dysfunction that is caused by a dysregulated host response to infec-
tion [2].
The pathophysiology of sepsis is complex and involves the interaction of the host with
infecting microorganisms. Infection control depends on the host cell recognizing microorgan-
isms, prompting an appropriate immune response. The interaction of cells from the immune
system with bacteria and their products occurs through preserved structures of microorgan-
isms known as pathogen-associated molecular patterns (PAMPs), which are recognized by the
pattern recognition receptors (PRRs) of innate immune cells. Lipopolysaccharide (LPS), which
is present in the outer membrane of gram-negative bacteria, and Toll-like receptor (TLR)-4,
which is present on the cell surface, are the best examples of such an interaction [3, 4]. Upon
LPS stimulation, transcription factors such as NF-kB are transferred to the nucleus and trigger
the transcription of multiple genes, including inflammatory cytokines, ROS and NO.
One of the main sources of ROS in the phagocytes is the NADPH oxidase, an enzyme com-
plex that consists of five subunits assembled upon cellular activation [5]. Under stress condi-
tions, mitochondria also play an important role in cellular oxidative stress and produce high
concentrations of ROS. These are related to mitochondrial damage and dysfunction and con-
tribute to the development of organ dysfunction and poor sepsis outcomes [6–8].
TLR signaling, NADPH-oxidase and oxidative phosphorylation are activated and interact
during host response to infection. Bacterial sensing, at the cell surface and upon phagocytoses,
will trigger TLR pathways, among other PRRs, and promote the assembly of NADPH-oxidase
and production of ROS to kill invading microorganisms. In recent years, in addition to its anti-
microbial role, NOX2-derived ROS emerged as a critical player in immune modulation [9].
Accordingly, the pretreatment of neutrophils with antioxidants prevented LPS-induced kinase
activation, nuclear translocation of NF-kappaB and the production of proinflammatory cyto-
kines [10]. Mitochondria oxidative phosphorylation and energy generation are both a target
and source of ROS. Increased levels of nitric oxide (NO) and superoxide (O2
-) have been
reported in septic patients, and their levels are related to outcomes [11, 12]. Oxidative stress
can impair the mitochondrial function in multiple ways. NO can modulate mitochondrial res-
piration and oxygen consumption through reversible binding and inhibition at complex IV,
leading to the accumulation of NADH and increases in ROS production [13]. NO and super-
oxide (O2
-) rapidly react to form peroxynitrite anion (ONOO). Because NO is a relatively sta-
ble and highly diffusible free radical and O2- is much shorter lived and has restricted diffusion
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across biomembranes, the sites of peroxynitrite formation are assumed to be spatially associ-
ated with the O2- sources, such as plasma membrane NAD(P)H oxidases and mitochondrial
respiratory complexes [14]. Mitochondrial enzymes are particularly vulnerable to peroxyni-
trite, leading to cessation of electron transport and ATP formation, mitochondrial swelling,
and permeabilization of the outer mitochondrial membrane, thus allowing the efflux of proa-
poptotic molecules, such as cytochrome c [14].
Besides their interactions we also considered that genes modulating different functions may
be differentially regulated in septic patients and that at the cellular level, different functions
might be differentially regulated. We demonstrated in previous studies that monocytes from
septic patients have decreased production of inflammatory cytokines, a preserved phagocytic
capacity and an increase in production of both NO and ROS, indicating a modulation in the
function of these cells during sepsis [15].
Here, we evaluated genes involved in the TLR signaling pathway, oxidative phosphorylation
and oxidative metabolism, aiming to assess their interactions and resulting cell functions and
pathways that are disturbed in septic patients. To partially avoid sepsis heterogeneity, we
selected patients with sepsis secondary to community-acquired pneumonia (CAP). Gene
expression and interactions were analyzed at admission and in follow-up samples for patients
surviving or dying from sepsis.
Materials and methods
Patients and healthy volunteers
Patients who were admitted from January 2008 to December 2009 to the intensive care units
of the Sao Paulo, Albert Einstein, and Sirio-Libanes Hospitals (all in Sao Paulo, Brazil) with a
clinical diagnosis of sepsis according to the ACCP/SCCM consensus conference [16] were
enrolled in a prospective cohort of septic patients [17, 18]. The study was approved by the eth-
ics committees of the participating hospitals, Sao Paulo Hospital (Study number 1477/06),
Albert Einstein Hospital (Study number 07/549) and Sirio Libanes Hospital (Study number
2006/27). Blood samples were collected in sodium heparin-treated tubes (BD Biosciences,
Franklin Lakes, NJ, USA), after written informed consent was collected from the patient or
representative next of kin. Blood samples obtained from 16 patients with sepsis secondary to
CAP were selected for this study. Samples were obtained at admission (D0), and 10 of the
patients had a second sample collected after 7 days (D7) of therapy. Samples were also collected
from 8 healthy volunteers who were matched according to age and gender.
Peripheral blood mononuclear cells
Peripheral blood mononuclear cells were obtained using the Ficoll gradient method (Ficoll-
Paque PLUS; GE Healthcare Bio-Sciences AB, Uppsala, Sweden), frozen in fetal bovine serum
(Invitrogen-Gibco, Gaithersburg, MD, USA) with 10% dimethyl sulfoxide (Calbiochem, La
Jolla, CA, USA) and stored in liquid nitrogen prior to use. Upon thawing, the cells were
washed and suspended in R10 (RPMI 1640 medium supplemented with 10% fetal bovine
serum, 1% HEPES buffer solution 100 mM, 1% L-glutamine 200 mM, 1% sodium pyruvate
100 mM, 1% penicillin/streptomycin 100X, and 0.1% 2-mercaptoethanol 55 mM, all from
Invitrogen). The standard cell concentration was 1X107 cells/mL.
Quantitative RT-PCR array
Total RNA was isolated using silica membrane from an RNEasy Mini-Kit (Qiagen, Hilden,
Germany). Samples were treated with DNase I (Qiagen). Total RNA quantification was
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obtained using a Nanodrop device. Purity and integrity were confirmed by spectrophotometry
(A260/A280 ratio), and 500 ng of RNA per sample was used for cDNA synthesis. Reverse tran-
scription reactions were performed using an RT2 First Strand Kit (Qiagen) according to the
manufacturer’s protocol. Sample quality was verified using RT2 RNA QC PCR Array plates
(Qiagen), which contain controls for RNA integrity, the presence of reverse transcription and
PCR amplification inhibitors, and the presence of genomic or other DNA contamination.
Real-time polymerase chain reactions were performed using the RT2 Customized Profiler™
PCR Array from Qiagen. For each sample, a total of 84 genes were analyzed (listed in Table 1).
For customization we choose the genes of interest, while the sequences of primers were the
standards of the manufacturer. Amplification, data acquisition, and melting curve analysis
were performed in a 7500 real time PCR system (Termo Scientific), and in each run, every
gene was checked for the efficiency, threshold point, baseline point and melting curve. To
enable a comparison between runs, the same threshold was established for all genes and runs.
Two genes (GAPDH and HPRT1) were used as internal controls, and the average of their Ct
values was used to normalize gene expression (2−ΔCt) and determine the fold change between
groups (2−ΔΔCt). Gene expression was considered up- or down-regulated when the fold change
was greater than 1.5.
Statistical analysis
Differences in gene expression were evaluated using Student’s t test for independent samples
with online software (Qiagen). A p-value of 0.05 was considered significant. The list of genes
and FC values was imported in the Ingenuity Pathway Analysis (IPA) (Ingenuity Systems, Red-
wood City, CA, USA) for evaluating the signaling cascade and predicting the likelihood of an
association between the set of altered genes and related pathways. The Fisher’s exact test from
IPA was used for this purpose.
Table 1. Genes evaluated in the PCR-array, grouped according to their function.
TLR signaling pathway (22)
TLR4 CD14 LY96 MYD88 IRAK3 NFKBIA NFKB1
TRAF6 ECSIT IRF5 CHUK IKBKG MAPK14 MAP2K7
RELA MAPK7 MAP2K3 MAPK8 JUN TICAM1 IRF7
IRF3
Interferons signaling pathway (12)
IFNAR1 IFNAR2 JAK1 TYK2 STAT1 STAT2 IRF9
IFNGR1 IFNGR2 JAK2 SOCS3 IRF1
Oxidative stress (17)
NOS1 NOS2 NOS3 SOD1 SOD2 SOD3 CYBB
RAC1 UCP2 GPX1 PRDX3 PRDX4 CAT TXN
TXNRD1 TXNRD2 NCF1
Oxidative phosphorylation (25)
NDUFA4 NDUFA5 NDUFA7 NDUFA8 NDUFA9 NDUFA10 NDUFA11
NDUFB5 NDUFB6 NDUFC2 COX4I2 COX5A COX5B COX6A2
COX7A2 COX7C COX10 ATP5B ATP5C1 ATP5F1 ATP5J
ATP6V1C1 ATP6V1E1 ATP6V1E2 UQCRC2
Cytokines (8)
TNF IL1B IFNA1 IFNB1 IL10 IL6 CXCL10
IL12A
doi:10.1371/journal.pone.0172024.t001
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Results
Casuistic and clinical data
Sixteen patients (D0) with sepsis secondary to pneumonia were enrolled in the study; 12.5%
had severe sepsis, and 87.5% had septic shock. Their mean age was 71.7 years, ranging from 45
to 93 years, and 75% were male. The mean SOFA (Sequential (sepsis) Organ Failure Assess-
ment) on day zero was 8±1.9, and the hospital mortality rate was 55.0%. The mean age for
healthy volunteers was 64.8 years, ranging from 35 to 86 years and 62.5% were male.
Gene expression at admission and follow-up
Gene expression in septic patients was analyzed in admission (D0) and follow-up samples
(D7) and according to patient’s outcomes, survivors and non-survivors. Among the 84 genes
that were studied, 22 genes were differently expressed in D0 samples. Among them, 19 were
down-regulated, and 3 were up-regulated; 15 of them had p<0.05 (Fig 1A). When gene expres-
sion was analyzed according to the outcomes, patients who survived presented with 21 differ-
ently expressed genes; only one gene was up-regulated, and nine of them had p<0.05 (Fig 1B).
In contrast, 42 genes had differential expression in non-surviving patients, 31 were down-reg-
ulated, and 11 were up-regulated; 31 had p<0.05 (Fig 1C).
Samples analyzed after 7 days of treatment also showed gene expression modulation com-
pared with the control group. Thirteen genes showed changes; 7 genes were down-regulated,
and 6 genes were up-regulated (Fig 2).
Gene expression and network of interactions in septic patients
Table 2 shows the fold change ratios in the gene expression of septic patients compared to the
healthy volunteers at admission and after seven days of follow-up, and according to the out-
comes. IPA was used to represent the altered gene expression involved in signaling pathways
for TLR, interferon and oxidative metabolism. At D0, genes related to TLR and the interferon
cascade were down-regulated (TRAF6, MAPK7, MAPK8, JUN, IRF7, IRF3 and JAK1, STAT1,
STAT2, IRF9, and IRF1), and a few of the genes involved in oxidative phosphorylation were
modulated; NDUFC2, COX412 and COX10 were down-regulated, and SOD2 was up-regu-
lated (Table 2, Fig 3A). When gene expression was analyzed according to the outcomes, 9
genes were differently expressed in surviving patients, and all were involved in the cascade of
TLR and Interferon. TRAF6, MAPK7, MAPK8, IRF7, JAK1, STAT1, IRF9, and IRF1 were up-
regulated and only IL10 was down-regulated (Table 2, Fig 3B). In contrast, 31 genes were mod-
ulated in non-surviving patients; they were mostly down-regulated. Down-regulated genes
included TRAF6, MAPK7, MAP2K7, MAPK8, JUN, IRF3 and IL12A, which were related to
TLR cascade; IFNAR1, JAK1, STAT2, IRF9 and IRF1, related to the interferon cascade; NOS3
and SOD1, related to oxidative metabolism; and NDUFA4, NDUFA5, NDUFA7, NDUFA10,
NDUFB5, NDUFB6, NDUFC2, COX7A2, COX7C, COX10, ATP5C1, ATP5F1 and
ATP6V1E2, which are specific to mitochondria metabolism. Only 4 genes were up-regulated:
IRAK3 and MAP2K3 were related to the TLR cascade, IFNGR2 was related to the interferon
cascade and SOD2 was related to mitochondria metabolism (Table 2, Fig 3C).
Seven genes were differently expressed in the follow-up samples. Among them, 5 were
down-regulated, including MAPK7 and JAK1, related to the TLR/Interferon cascade, and
SOD1, NDUFC2 and ATP6V1E2, related to the oxidative/mitochondria metabolism cascade;
2 genes were up-regulated, i.e., SOD2 and GPX1, which are both related to the oxidative/mito-
chondria metabolism cascade (Fig 4).
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Canonical pathways differently regulated during sepsis
We evaluated the canonical pathways that were affected by changes in the expression of the 84
genes studied in the D0 and D7 samples and according to the patient outcomes, i.e., survivors
and non-survivors.
The canonical pathways altered in D0 samples included IL-10 signaling, interferon and
INOS signaling; the role of JAK1, JAK2 and TYK2 in interferon signaling; mitochondrial dys-
function; and superoxide radical degradation pathways (Fig 5A). When analyzed according to
Fig 1. Volcano plot representing the gene expression changes in admission samples (D0) of septic patients compared to
healthy volunteers. A. all patients; B. survivors; and C. non-survivors. The x axis represents the Log2 fold change and Y axis—Log10 P
value. The cut off for significance is set as the fold change 1.5 and P value 0.05. The genes are represented as dots, where the green
color represents down regulation, red represents up regulation and gray indicates no significant changes.
doi:10.1371/journal.pone.0172024.g001
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outcomes, different pathways were prominent in surviving and non-surviving patients. IOf
note, the mitochondrial dysfunction, oxidative phosphorylation and superoxide radical degra-
dation pathway were more altered in non-surviving patients (Fig 5B and 5C).
Four canonical pathways were disturbed at D7, and there was a greater representation of
down-regulated genes in superoxide radical degradation; a role of JAK1, JAK2 and TYK2 in
the interferon signaling pathway; interferon signaling; and INOS signaling (data not shown).
Direct comparison between survivors and non-survivors showed differences in the canoni-
cal pathways (S1A Fig), and lower degree of inflammatory response (quantity of nitric oxide,
recruitment and activation of phagocytes) in survivors than in non-survivors (S1B Fig).
Discussion
Our study evaluated the expression of genes related to TLR signaling, mitochondrial oxida-
tive phosphorylation and oxidative stress in septic patients. We found differences between
patients and healthy volunteers and, importantly, between survivors and non-survivors. This
is consistent with previously reported transcriptomics studies from our group, which showed
Fig 2. Volcano plot representing gene expression changes in follow-up samples (D7) of septic
patients compared to healthy volunteers. A. all patients; B. survivors; and C. non-survivors. The x axis
represents Log2 fold change and Y axis—Log10 P value. The cut off for significance is set as a fold
change 1.5 and P value 0.05. The genes are represented as dots, where the green color represents
down regulation, red represents up regulation and black indicates no significant changes.
doi:10.1371/journal.pone.0172024.g002
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Table 2. Fold change ratios in the gene expression of septic patients compared to the healthy volunteers at admission and after seven days of fol-
low-up, according to the outcomes.
D0 D7
Gene All (N = 16) S (N = 8) NS(N = 8) All (N = 10)
TLR4 1.08 -1.06 1.25 1.05
CD14 1.17 1.05 1.34 -1.11
LY96 1.1 1.02 1.24 -1.12
MYD88 1.1 -1.06 1.25 -1.01
IRAK3 1.41 1.21 1.64 a 1.3
TRAF6 -1.81 a -1.70 a -2.14 a -1.47
ECSIT -1.3 -1.31 -1.35 -1.23
IRF5 -1.22 -1.08 -1.35 -1.11
CHUK -1.04 -1.21 1.01 -1.1
IKBKG -1.12 -1.09 -1.14 1.09
NFKBIA 1.22 -1.21 1.62 1.35
NFKB1 1.09 1.17 1.08 -1.16
RELA (p65) -1.41 -1.38 -1.45 -1.34
MAPK7 (ERK) -1.86 a -1.69 a -2.14 a -1.66 a
MAP2K3 (MKK3) 1.29 1.2 1.52 a 1.05
MAPK14 1.24 1.21 1.32 1.25
MAP2K7 (MKK7) -1.49 -1.39 -1.66 a -1.25
MAPK8 (JNK1) -1.74 a -1.69 a -1.85 a -1.41
JUN (AP1) -2.05 a -1.70 -2.78 a -1.43
TICAM1 -1.11 -1.33 1 -1.17
IRF7 -1.54 a -1.73 a -1.50 -1.35
IRF3 -1.61 a -1.58 -1.70 a -1.37
IFNAR1 -1.23 -1.08 -1.51 a -1.27
IFNAR2 -1.2 -1.12 -1.39 -1.53
JAK1 -1.80 a -1.68 a -2.22 a -1.64
TYK2 -1.37 -1.31 -1.47 -1.29
STAT1 -1.78 a -2.46 a -1.80 -1.13
STAT2 -1.58 a -1.72 -1.77 a -1.36
IRF9 -1.52 a -1.66 a -1.61 a -1.19
IFNGR1 (IFNGR) 1.04 1.13 1.04 1.11
IFNGR2 (AF-1) 1.46 1.4 1.60 a 1.23
JAK2 -1.48 -1.69 -1.57 -1.17
SOCS3 -1.07 -1.02 -1.22 -1.23
IRF1 -1.94 a -2.37 a -2.17 a -1.36
NOS1 1 -1.35 1.46 -1.4
NOS2 -1.09 -1.02 -1.12 -1.34
NOS3 -2.54 -1.91 -3.52 a -1.85
SOD1 -1.6 -1.4 -2.02 a -1.56 a
SOD2 2.15 a 1.37 3.45 a 2.12 a
SOD3 -1.35 -1.59 1.03 -1.12
CYBB (gp91) -1.1 -1.35 1.11 -1.1
NCF1 (p47phox) 1.15 -1.06 1.52 1.56
RAC1 -1.03 -1.05 -1.12 -1.04
UCP2 -1.31 -1.42 -1.38 -1.1
GPX1 1.34 1.41 1.46 1.58 a
(Continued)
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Table 2. (Continued)
D0 D7
Gene All (N = 16) S (N = 8) NS(N = 8) All (N = 10)
PRDX3 -1.07 -1.02 -1.27 -1.17
PRDX4 -1.04 1.13 -1.35 1
CAT 1 -1.02 -1.03 -1.15
TXN 1.11 1.1 1.17 1.03
TXNRD1 -1.12 -1.11 -1.22 -1.07
TXNRD2 -1.22 -1.22 -1.26 -1.21
NDUFA4 -1.41 -1.37 -1.55 a -1.31
NDUFA5 -1.41 -1.06 -1.86 a -1.22
NDUFA7 -1.35 -1.34 -1.54 a -1.26
NDUFA8 -1.18 -1.17 -1.28 -1.11
NDUFA9 -1.38 -1.37 -1.49 -1.21
NDUFA10 -1.39 -1.28 -1.57 a -1.28
NDUFA11 -1.19 -1.15 -1.16 -1.21
NDUFB5 -1.45 -1.35 -1.73 a -1.33
NDUFB6 -1.37 -1.31 -1.58 a -1.22
NDUFC2 -1.90 a -1.77 -2.31 a -1.58 a
COX4I2 -1.83 a -1.91 -1.62 -1.39
COX5A -1.15 -1.02 -1.36 -1.16
COX5B -1.29 -1.33 -1.28 -1.19
COX6A2 1.18 -1.01 1.31 -1.26
COX7A2 -1.29 -1.12 -1.59 a -1.36
COX7C -1.49 -1.4 -1.67 a -1.34
COX10 -1.66 a -1.65 -1.74 a -1.30
ATP5B -1.2 -1.16 -1.27 -1.17
ATP5C1 -1.32 -1.22 -1.56 a -1.28
ATP5F1 -1.4 -1.26 -1.76 a -1.34
ATP5J -1.18 -1.12 -1.33 -1.18
ATP6V1C1 1.22 1.24 1.12 1.04
ATP6V1E1 -1.17 -1.13 -1.23 -1
ATP6V1E2 -1.56 -1.28 -1.97 a -1.51 a
UQCRC2 -1.41 -1.46 -1.43 -1.29
TNF 1.04 -1.99 1.54 1.3
IL1B 1.38 -2.24 2.9 1.56
IFNA1 -1.04 -1.05 1.18 -1.16
IFNB1 1.12 -1.49 1.67 1.58
IL10 1.96 2.87 a 1.73 1.22
IL6 3.6 1.08 7.42 2.23
CXCL10 -2.49 -5.16 -2.02 -1.49
IL12A -1.5 -1.28 -2.29 a -1.22
Footnote: D0 represents total septic patients after admission and D7 represents samples obtained after 7 days. S: survivors and NS: non-survivors. The
bold letters show fold change1.5 and the letter “a” indicates P value0.05.
doi:10.1371/journal.pone.0172024.t002
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Fig 3. Demonstration of differential gene expression profile in septic patients in admission (D0)
samples using curated pathway functional of IPA. A. all patients; B. survivors; and C. non-survivors. Gene
expression changes with FC 1.5 and P value 0.05 were used to generate the interaction network. The
intensity of the color represents up-regulation (red), down-regulation (green) or no significant regulation
(gray).
doi:10.1371/journal.pone.0172024.g003
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that principal component analyses segregated survivors from non-survivors [19], and other
studies, including those on trauma and septic patients, in which gene expression was differ-
ent between complicated and uncomplicated cases or survivors and non-survivors [20, 21].
In a recent study, the global gene expression of blood leukocytes from patients with CAP
showed marked changes compared with healthy volunteers. Common and unique altered
genes were shown in CAP and no-CAP patients, allowing the identification of biomarkers
discriminating CAP from no-CAP patients, without discriminating between CAP survivors
and non-survivors [22].
In the present study, we found TLR and interferon cascades were down-regulated in admis-
sion samples. Few of the genes involved in oxidative phosphorylation were differentially mod-
ulated. Down-regulation of the TLR signaling pathways in the PBMCs of septic patients was
seen in a previous study performed by our group [23]. Despite preserved TLR gene expression,
key downstream genes such as NF-κB have been consistently reported to be down—regulated.
Accordingly, we found preserved TLR2 and TLR4 detection on the monocyte cell surface and
impaired response to LPS in septic patients [24].
Overall, the changes in gene expression was qualitatively similar in survivors and non-sur-
vivors, with differences appearing in the magnitude of the disturbance, as previously reported
by Xiao et al in a transcriptome study of trauma patients [20]. Accordingly, lower number of
genes was modulated in surviving than in non-surviving patients (shown in Fig 1 and Table 2),
and most genes altered in survivors were also altered in non-survivors. As expected, these
changes resulted in similar canonical pathways affected in both groups, yet with different posi-
tion in the top altered ones (Fig 5).
LPS induces TLR4 signaling through two pathways: the MyD88-dependent pathway
induces an early activation of nuclear factor-κB (NF-κB), which leads to the production of
inflammatory cytokines, and the MyD88-independent pathway or TRIF-dependent pathway
Fig 4. Gene expression changes and network of interactions between control and septic patients after 7 days. Gene expression
changes with FC 1.5 and P value 0.05 were used to generate the interaction network. The intensity of the color represents up-
regulation (red), down-regulation (green) or no regulation (gray).
doi:10.1371/journal.pone.0172024.g004
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Fig 5. Canonical pathways affected by changes in gene expression during sepsis. A. all patients; B.
survivors; and C. non-survivors. The percentage of up-regulated and down-regulated genes in each selected
canonical pathway can be measured in the percentage scale given on the y-axis (left side), in which red
corresponds to the up-regulated genes and green corresponds to the down-regulated genes. The yellow line
represents the −log (p-value) of affected genes in a given pathway. Canonical pathways with −log (p-value)
higher than 4.5 are represented.
doi:10.1371/journal.pone.0172024.g005
TLR cascades, mitochondrial oxidative phosphorylation and oxidative stress in septic patient
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induces the activation of interferon (IFN)-regulatory factor 3 (IRF3) and the late activation of
NF-κB, which leads to the production of IFN-beta and IFN-inducible genes [1]. We were
interested to evaluate representative genes in IFN-induced cascade because of the controversy
regarding TRIF-dependent pathway regulation during LPS tolerance. Depending on experi-
mental approaches, authors have found that the induction of TRIF-dependent IFN-α/β and
IFN-induced genes is enhanced in LPS-tolerant cells [25], while others reported that non-tol-
erant genes are not regulated through IFN-α/β feedback [26]. In a previous work analyzing
human tolerant PMBCs, we could see that TRIF and IFN-β were down-regulated upon re-
stimulation with LPS [27]. In the present work, we found down-regulation of these genes in all
septic patients, and accordingly to the outcomes, in survivors and in non-survivors (Table 2
and Fig 3) compared with the healthy volunteers. Accordingly, interferon signaling and role of
JAK1, JAK2 and TYK2 in the interferon signaling pathways are among the top relevant canon-
ical pathways altered in our patients (Fig 5). It is known that the JAK / STAT pathway is related
to the release of cytokines and inflammatory mediators, such as IL-6, IL-10 and iNOS. There
are few studies current evaluating its role in sepsis [28]. In experimental studies, inhibition of
JAK2 with AG490 or STAT3 with rapamycin attenuated organ damage and severe sepsis mor-
tality [29, 30]. Additionally, septic mice deficient in TYK2 and STAT1 had a higher survival
rate than did wild-type animals. This improvement in survival was associated with less hypo-
thermia, hypoglycemia and hepatocellular injury [31].
Notably, genes encoding the subunits of the mitochondria complex, which are involved in
oxidative phosphorylation, were negatively modulated in non-surviving and much less affected
in surviving patients (Table 2, Fig 3). In fact, genes related to mitochondrial oxidative phos-
phorylation from complexes I, IV and V were down-regulated, as were those involved in scav-
enging mtROS, such as SOD1 and SOD3, catalase, peroxiredoxin (PRDX)-3 and 4,
thioredoxin reductase (TXNDRD) 1 and 2. Accordingly, mitochondrial dysfunction and oxi-
dative phosphorylation components were among the most altered canonical pathways in non-
surviving patients.
There are several studies showing impairment in the mitochondrial function of patients
dying from sepsis. Brealey et al. observed reduced activity of complex I in the mitochondria
and ATP content in the skeletal muscle in non-surviving patients [32]. Studies in PBMCs and
monocytes of septic patients showed changes in mitochondrial function, such as a reduction
in the respiration and/or enzymatic activity of all complexes and in the potential membrane
[33–36]. Experimental work allows for studying mitochondria in other tissues. A reduction in
the efficiency of oxidative phosphorylation and activity of complex IV has been shown in the
brain tissue of mice [37]. Commin et al. observed that rats that suffered CLP showed decreased
activity of complex I, but not of the complexes II, III and IV in the electron transport chains
[38]. In contrast, increased consumption of oxygen and breathing efficiency was demonstrated
in the livers of septic rats [39].
Expression of p47phox (NCF1) and gp91 (CYBB) was not altered in septic patients in the
admission samples, except for the increased expression of NCF1 in non-survivors. This might
indicate that ROS generation at the phagolysosomes might be preserved. This is supported by
our previous results, showing increased assembly of NADPH-oxidase, preserved phagocytic
activity and increased ROS generation in monocytes from septic patients [15].
In conclusion, our data show changes in the expression of genes belonging to the interact-
ing TLR cascades, NADPH-oxidase and oxidative phosphorylation. Importantly, distinct pat-
terns are clearly observed in surviving and non-surviving patients. Interferon signaling,
marked by changes in JAK-STAT modulation, had prominent changes both in survivors and
non-survivors, whereas oxidative phosphorylation affecting mitochondrial functions was
prominent in non-surviving patients.
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Our study has limitations. One is the low sample size. In part, it is because we selected only
those patients with CAP as the source of infection from the cohort of septic patients, aiming to
minimize the patient heterogeneity. Additionally, our results are largely based on gene expres-
sion. Nevertheless, the conclusions driven from our present data are in agreement with previ-
ous functional studies from our group and others.
Supporting information
S1 Fig. Comparative analysis between survivor and non-survivor patients using IPA. A.
altered canonical pathways; B. functional alterations.
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